首页> 外文会议>International conference on screening for lung cancer >The impact of the type of resection on survival in patients with N1 non-small-cell lung cancers
【24h】

The impact of the type of resection on survival in patients with N1 non-small-cell lung cancers

机译:切除术对N1非小细胞肺癌患者存活的影响

获取原文

摘要

Objective:Complete resection is the therapy of choice in non-small-cell lung cancer (NSCLC). There is no agreement on the type of resection,especially when interlobar N1 disease is present. The present study explored the effect of the type of resection on survival in the presence of N1 disease.Method:Medical records of 195 patients with NSCLC who underwent resection between 1998 and 2006 and whose histopathological examination showed N1 disease were reviewed retrospectively. This study included 162 patients with Tstatus of T1,T2 or T3,who had complete resection (excluding superior sulcus tumours). The patients were divided into three groups,namely hilar N1 (n=15,9.3%),interlobar N1 (N1 -i) (n=54,33.3%) and lobar N1 (n=93,57.4%).Frequency comparisons were carried out by chi-square test.Survival rates were calculated by the Kaplan-Meier method and compared by log-rank test after patients who had operative mortality (n=10,6.2%) were excluded.Results:Seventy-seven patients (47.5%) had lobectomy,14 (8.6%) had bilobectomy (BL) and 71 (43.8%) had pneumonectomy (PN). Twenty-one of these patients (13.0%) had sleeve lobectomy and 19 had (11.7%) additional interventions (such as resection of the diaphragm or thoracic wall). Among all N1 patients,5-year survival rate was 56.9% in patients who had BL or PN and 46.8% in patients who had lobectomy,a difference not statistically significant (p=0.09).Similarly,there was no significant difference between patients who had sleeve resection and PN (p=0.58). The type of resection was not found related to survival in the presence of interlobar (p =0.75).Similarly,type of resection was not significantly associated with survival in patients with hilar N1 (p=0.86).Conclusion:Those who had PN or BL had a higher survival rate,which was statistically insignificant.Further studies are required to determine whether or not the type of resection should be changed as a result of N1 only.
机译:目的:完全切除是在非小细胞肺癌(NSCLC)中选择的选择。没有关于切除类型的一致性,特别是当存在白细胞N1疾病时。本研究探讨了切除类型对N1疾病存在生存的影响。方法:1998年至2006年间切除切除的195例NSCLC患者的医学记录,其组织病理学检查显示N1疾病进行了回顾性。本研究包括162例TSTATUS的TSTATUS,T1,T2或T3患者,他完全切除(不包括上级沟槽肿瘤)。将患者分为三组,即Hilar N1(n = 15,9.3%),白细胞N1(N1-I)(n = 54,33.3%)和洛巴尔N1(n = 93,57.4%)。频率比较是通过Chi-Square Test.Survival率通过Kaplan-Meier方法计算,并通过患有手术死亡率(n = 10,6.2%)的患者进行测定率测试比较。结果:七十七名患者(47.5 %)具有肺叶切除术,14(8.6%)具有BiLobectomy(BL)和71(43.8%)具有肺切除术(PN)。这些患者中的二十一岁(13.0%)具有袖子叶梭眼切除术,19例(11.7%)(11.7%)另外的干预(如切除隔膜或胸壁)。在所有N1患者中,5年生存率为56.9%,患者患有BL或PN和46.8%的患者,患者患者,差异没有统计学意义(p = 0.09)。杀菌剂之间,患者之间没有显着差异有套筒切除和pn(p = 0.58)。没有发现切除类型与中间隙存在的生存有关(p = 0.75)。相似的,切除类型与肝脏N1患者的存活无显着相关(p = 0.86)。结论:那些有pn或pn的人BL具有较高的存活率,其存在统计学微不足道。需要研究才能确定切除类型是否应该因N1而改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号